Chronic graft-versus-host disease (GVHD) remains a common and potentially life-
threatening complication of allogeneic hematopoietic stem cell transplantation (HCT). The 2 …

Chronic graft-versus-host disease (GVHD) is a frequent and potentially life-threatening
complication of allogeneic hematopoietic stem cell transplantation. Increased …

Several international recommendations address the assessment of graft-versus-host
disease (GvHD) after hematopoietic cell transplantation (HCT). This position statement by …

GVHD remains the major impediment to broader application of allogeneic haematopoietic
SCT. It can be prevented completely, but at the expense of other complications, rejection …

Graft-versus-host disease (GVHD) is an immunological reaction and a frequent complication
following allogeneic hematopoietic stem cell transplantation. It is associated with high …

Background After the first investigational study on the use of extracorporeal photopheresis
for the treatment of cutaneous T‐cell lymphoma was published in 1983 with its subsequent …

Background Following the first investigational study on the use of extracorporeal
photopheresis for the treatment of cutaneous T‐cell lymphoma published in 1983, this …

Allogeneic hematopoietic stem cell transplantation is hampered by chronic graft-versus-host
disease (cGVHD), resulting in multiorgan fibrosis and diminished function. Fibrosis in lung …

Allogeneic hematopoietic stem cell transplantation is a definitive therapy for a variety of
disorders. One of the complications is acute graft-versus-host disease (aGVHD), which has a …

A major obstacle of allogeneic haematopoietic stem cell transplantation is graft-versus-host
disease, an immune-mediated disorder that affects multiple tissues and organs with varying …